Skip to main content
Log in

Suppression of human nasopharyngeal carcinoma cell growth in nude mice by the wild-type p53 gene

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Wild-type and mutant human p53 genes were transfected into the nasopharyngeal carcinoma (NPC) cell line CNE-3. Tumorigenicity in nude mice showed that the tumor resulting from the cells transfected with the wild-type p53 gene grew more slowly and was smaller than that from the cells transfected with mutant p53 gene and that from control CNE-3 cells. In contrast, the tumor from the cells transfected with the mutant p53 gene grew faster than that produced by cells transfected with the wild-type p53 gene and that produced by control CNE-3 cells. The results demonstrate that the wild-type p53 gene could inhibit the NPC cell growth in nude mice and the mutant p53 gene could enhance the NPC cell growth in nude mice. The p53 gene may also play an important role in the pathogenesis of NPC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NPC:

nasopharyngeal carcinoma

References

  • Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–919

    PubMed  Google Scholar 

  • Bressac B, Kev M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–431

    PubMed  Google Scholar 

  • Finlay CA, Hinds PM, Levine AJ (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093

    PubMed  Google Scholar 

  • Hinds P, Finlay C, Levine AJ (1989) Mutation is required to activate p53 gene for cooperations with the ras oncogene and transformation. J Virol 63:739–736

    PubMed  Google Scholar 

  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428

    PubMed  Google Scholar 

  • Lane DP, Crawford LV (1979) T antigen is found to host protein in SV40-transformed cells. Nature 278:261–263

    PubMed  Google Scholar 

  • Linzer DIH, Levine AJ (1979) Characterzation of a 54 kdalton cellular SV40 tumour antigen present in SV40-tranformed cells and uninspected embryonal carcinoma cells. Cell 17:43–52

    PubMed  Google Scholar 

  • Nigro JM, Baker SJ, Preisinger AC, Jessuo JM et al. (1989) Mutations in the p53 gene occur in diverse human tumors types. Nature 342:705–708

    PubMed  Google Scholar 

  • Rhim JS, Park JB, Jay G (1989) Neoplastic transformation of human keratinocytes by polybrene-induced DNA mediated transfer of an activated oncogene. Oncogene 4:1403–1409

    PubMed  Google Scholar 

  • Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumour antigen: analysis of mRNA levels in normal abult tissuse, embryos and tumours. Mol Cell Biol 5:2851–2855

    PubMed  Google Scholar 

  • Sarnow P, Ho YS, Williams J, Levine AJ (1982) Adenovirus E1b-58 kd tumour antigen and SV40 large tumour antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387–394

    PubMed  Google Scholar 

  • Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus 16 and 18 E6 proteins with p53. Science 248:76–79

    Google Scholar 

  • Zeng Y (1985) Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44:121–138

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, W., Lee, Y., Wang, H. et al. Suppression of human nasopharyngeal carcinoma cell growth in nude mice by the wild-type p53 gene. J Cancer Res Clin Oncol 119, 46–48 (1992). https://doi.org/10.1007/BF01209487

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01209487

Key words

Navigation